Back to Agenda
Indonesia Town Hall
Session Chair(s)
Endang Wahjuningtyas Hoyaranda
President
Indonesian Association for the Student of Medicinals (IASEMD), Indonesia
The Indonesian regulation for clinical research has shown a significant transformation during the past year, after practically being at a very low level for the past decade. The Ministry of Health, together with the Indonesian Drug and Food Regulatory Body are prepared to welcome global pharmaceutical companies to conduct researches in various hospitals in the country.
Learning Objective : Analyze the recent transformations in Indonesian clinical research regulations and their impact on the country's research environment; Evaluate the opportunities and challenges for global pharmaceutical companies conducting clinical research in Indonesia under the new regulatory framework.
Speaker(s)
Panelist
Yuli Felistia
National Brain Center, Mahar Mardjono Hospital, Indonesia
Head of Clinical Research Unit, Research Manager
Panelist
Representative Invited
Indonesia Food and Drug Authority, Indonesia
Panelist
Indri Rooslamiati
Indonesia Ministry of Health, Indonesia
Head of Indonesia Clinical Research Center INA-CRC
Panelist
Budi Sadikin, PhD
Ministry of Health, Indonesia
Minister of Health
Panelist
Representative Invited
Indonesia Food and Drug Authority, Indonesia
Have an account?